Details |
title |
year |
Details |
Panel Discussion: Optimal Lesion Set for Atrial Fibrillation ... |
2016 |
Details |
30th Anniversary Celebration of Women in Thoracic Surgery: Innovations and ... |
2016 |
Details |
International Symposium & Reception: The Ethics and Practicality of Using N... |
2016 |
Details |
Development of Guidelines and Policy in Lung Cancer Screening ... |
2016 |
Details |
Proposed Paris Categories in Atypical Urines: Improving the Filter for a Wa... |
2016 |
Details |
Intraobserver Agreement and Reproducibility for Retroareolar Frozen Section... |
2016 |
Details |
Longstanding Illness With No Definite Diagnosis: A Fatal Case of Undiagnose... |
2016 |
Details |
Bethesda Does Not Solve All the Problems: The Importance of a Second Opinio... |
2016 |
Details |
PL03: PRESIDENTIAL SYMPOSIUM TUESDAY, DECEMBER 6, 2016 - 08:35-10:25 PL03... |
2016 |
Details |
SESSION PL04A: IMMUNE CHECKPOINT INHIBITORS IN ADVANCED NSCLC WEDNESDAY, D... |
2016 |
Details |
3RD-LINE LOCALLY ADVANCED OR METASTATIC, EGFR/ALK WILD-TYPE NSCLC: RESULTS... |
2016 |
Details |
PL04: IMMUNE CHECKPOINT INHIBITORS IN ADVANCED NSCLC WEDNESDAY, DECEMBER ... |
2016 |
Details |
PL03: PRESIDENTIAL SYMPOSIUM TUESDAY, DECEMBER 6, 2016 - 08:35-10:25 PL03... |
2016 |
Details |
PL03: PRESIDENTIAL SYMPOSIUM TUESDAY, DECEMBER 6, 2016 - 08:35-10:25 PL03.... |
2016 |
Details |
SC06: NOVEL THERAPIES IN MALIGNANT PLEURAL MESOTHELIOMA AND THYMIC MALIGNA... |
2016 |
Details |
YI01A: CLINICAL TRIALS & SCIENTIFIC MENTORING SUNDAY, DECEMBER 04, 2016 - ... |
2016 |
Details |
OA03: IMMUNOTHERAPY CHECKPOINT INHIBITORS IN ADVANCED NSCLC MONDAY, DECEMB... |
2016 |
Details |
OA03: IMMUNOTHERAPY CHECKPOINT INHIBITORS IN ADVANCED NSCLC MONDAY, DECEMB... |
2016 |
Details |
OA04: EPIDEMIOLOGY AND PREVENTION OF LUNG CANCER MONDAY, DECEMBER 5, 2016 ... |
2016 |
Details |
OA05.01 PEMBROLIZUMAB IN PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CAN... |
2016 |